18.03.2014
- Novozymes Biopharma, part of Novozymes A/S, has announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate...
13.12.2013
- The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...
07.02.2013
- Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...
16.05.2012
- Britain's drug watchdog has reversed a controversial decision not to fund a new prostate cancer pill that was developed in the country after maker Johnson & Johnson agreed a new...
10.05.2012
- A U.S. Senate panel has launched a probe of possible links between three drugmakers and nonprofit medical groups that advocated for increasing the use of prescription painkillers...
10.08.2011
- Healthcare giant Johnson & Johnson has reached an agreement to settle a single misdemeanor charge related to its antipsychotic treatment Risperdal, the company said in a regulatory...
